Transcript

Matthew Regulski, DPM, FFPM, RCPS (Glasgow):

Hello, my name is Dr. Matthew Regulski. I'm the Medical Director of the Wound Institute of Ocean County in Toms River, New Jersey, Senior Partner at Ocean County Foot and Ankle Surgical Associates in Toms River, New Jersey. I've been in practice 22 years concentrating on diabetic wound healing, limb salvage, and reconstructive surgery.

In the poster that I did utilizing the synthetic biomimetic matrix, very novel self-assembling peptides, and the use of multispectral analysis and wound healing, I think is critical. Now the biomimetic matrix is an exceptional quality of different proteins that can do things inside the wound that mimic almost a skin graft, so to speak. And then these proteins do a lot of things to elaborate arginine, nitroxide, and the androgenic cascade. It’s very powerful and very compelling. 

In confirming that the oxygen that it did produce by utilizing the multispectral analysis, just confirmed how, in the interim, as it was healing the wound and increasing the androgenic cascade, the MIMOSA device was able to show the increase in the oxygenation, correlating with the decrease in wound size. Because as we all know, we need to have proper blood flow into a wound to bring all the oxygen cells and nutrients and special proteins that are utilized in the wound healing cascade. So, using a combination of those, it was verified showing how this novel synthetic biomimetic matrix of self-assembling peptides was in ways crucial to the wound healing process.